Alzheimer’s disease-related alterations in synaptic density: neocortex and hippocampus.

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123

The Global Deterioration Scale for assessment of primary degenerative dementia

Reisberg, ‌., Ferris, S. H., de Leon, M. J., & Crook, T. H. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.9.1136 · Cited by 5,122

Current concepts in mild cognitive impairment

Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397

The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects

Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117

Some new, simple and efficient stereological methods and their use in pathological research and diagnosis.

GUNDERSEN, H. J. G., BENDTSEN, T. F., KORBO, L., MARCUSSEN, N., MØLLER, A., NIELSEN, K., NYENGAARD, J. R., PAKKENBERG, B., SØRENSEN, F. B., VESTERBY, A., et al. (1988) · APMIS · doi:10.1111/j.1699-0463.1988.tb05320.x · Cited by 2,929

The unbiased estimation of number and sizes of arbitrary particles using the disector

Sterio, D. C. (1984) · Journal of Microscopy · doi:10.1111/j.1365-2818.1984.tb02501.x · Cited by 2,533

Diagnosis of Alzheimer's Disease

Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499

The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis

Gundersen, H. J. G., Bagger, P. V., Bendtsen, T. F., Evans, S. M., Korbo, L., Marcussen, N., Møller, A., Nielsen, K. N., Nyengaard, J. R., Pakkenberg, B., et al. (1988) · Apmis · doi:10.1111/j.1699-0463.1988.tb00954.x · Cited by 2,480

Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity

DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376

Increased Amyloid-β Peptide-Induced Memory Deficits in Phospholipid Transfer Protein (PLTP) Gene Knockout Mice

Desrumaux, C. M., Pisoni, A., Meunier, J., Deckert, V., Athias, A., Perrier, V., Villard, V., Lagrost, L., Verdier, J., & Maurice, T. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.247 · Cited by 48

Melatonin Stimulates Dendrite Formation and Complexity in the Hilar Zone of the Rat Hippocampus: Participation of the Ca++/Calmodulin Complex

Domínguez-Alonso, A., Valdés‐Tovar, M., Solís‐Chagoyán, H., & Benítez‐King, G. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16011907 · Cited by 48

Alzheimer’s Disease, Neural Plasticity, and Functional Recovery

Mercerón‐Martínez, D., Ibaceta-González, C., Salazar, C., Almaguer‐Melian, W., Bergado, J. A., & Palacios, A. G. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201178 · Cited by 48

Early Molecular Changes in Alzheimer Disease: Can We Catch the Disease in its Presymptomatic Phase?

Wirz, K. T. S., Keitel, S., Swaab, D. F., Verhaagen, J., & Bossers, K. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130920 · Cited by 47

Oleanolic Acid Ameliorates Aβ25-35 Injection-induced Memory Deficit in Alzheimer’s Disease Model Rats by Maintaining Synaptic Plasticity

Wang, K., Sun, W., Zhang, L., Guo, W., Xu, J., Liu, S., Zhou, Z., & Zhang, Y. (2018) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527317666180525113109 · Cited by 47

Neuroligin-1 is altered in the hippocampus of Alzheimer’s disease patients and mouse models, and modulates the toxicity of amyloid-beta oligomers

Dufort‐Gervais, J., Provost, C., Charbonneau, L., Norris, C. M., Calon, F., Mongrain, V., & Brouillette, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-63255-6 · Cited by 48

Synaptic Changes in the Dentate Gyrus of APP/PS1 Transgenic Mice Revealed by Electron Microscopy

Alonso-Nanclares, L., Merino-Serrais, P., Gonzalez, S., & DeFelipe, J. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31828d41ec · Cited by 45

Library screening by fragment‐based docking

Danzhi Huang, A., & Caflisch, A. (2009) · Journal of Molecular Recognition · doi:10.1002/jmr.981 · Cited by 45

Protection from Amyloid β Peptide–Induced Memory, Biochemical, and Morphological Deficits by a Phosphodiesterase-4D Allosteric Inhibitor

Cui, S.-Y., Yang, M.-X., Zhang, Y.-H., Zheng, V., Zhang, H.-T., Gurney, M., Xu, Y., & O'Donnell, J. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.259986 · Cited by 34

The multifaceted role of WNT signaling in Alzheimer’s disease onset and age-related progression.

Kostes, W. W., & Brafman, D. A. (2023) · Cells · doi:10.3390/cells12081204 · Cited by 43

Microglial p53 activation is detrimental to neuronal synapses during activation-induced inflammation: Implications for neurodegeneration

Jebelli, J. D., Hooper, C., & Pocock, J. M. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.08.049 · Cited by 43

Recent developments with tau-based drug discovery

Iqbal, K., Liu, F., & Gong, C. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1445084 · Cited by 46

Fluoxetine delays the cognitive function decline and synaptic changes in a transgenic mouse model of early Alzheimer's disease

Zhou, C., Chao, F., Zhang, Y., Jiang, L. H., Zhang, L., Fan, J., Wu, Y., Dou, X., & Tang, Y. C. (2018) · The Journal of Comparative Neurology · doi:10.1002/cne.24616 · Cited by 47

microRNA-34a (miRNA-34a) Mediated Down-Regulation of the Post-synaptic Cytoskeletal Element SHANK3 in Sporadic Alzheimer's Disease (AD)

Zhao, Y., Jaber, V. R., LeBeauf, A., Sharfman, N. M., & Lukiw, W. J. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00028 · Cited by 44

Neuroprotective Effects of a Specific Multi-Nutrient Intervention Against Aβ42-Induced Toxicity in Rats

de Wilde, M. C., Penke, B., van der Beek, E. M., Kuipers, A. A. M., Kamphuis, P. J. G. H., & Broersen, L. M. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110635 · Cited by 44

A Novel Therapeutic Approach to Treat Alzheimer’s Disease by Neurotrophic Support During the Period of Synaptic Compensation

Baazaoui, N., & Iqbal, K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170839 · Cited by 45

Astrocyte mediated MMP-9 activation in the synapse dysfunction: An implication in Alzheimer disease

Kamat, P. K., Swarnkar, S., Rai, S., Kumar, V., & Tyagi, N. (2015) · Therapeutic Targets for Neurological Diseases · doi:10.14800/ttnd.243 · Cited by 42

Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer’s disease models

Corsetti, V., Borreca, A., Latina, V., Giacovazzo, G., Pignataro, A., Krashia, P., Natale, F., Cocco, S., Rinaudo, M., Malerba, F., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa039 · Cited by 42

Developmental neurotoxicity of PFOA exposure on hiPSC-derived cortical neurons

Wu, S., Xie, J., Zhao, H., Zhao, X., Sánchez, O. F., Rochet, J., Freeman, J. L., & Yuan, C. (2024) · Environment International · doi:10.1016/j.envint.2024.108914 · Cited by 41

Synapse Loss in Olfactory Local Interneurons Modifies Perception

Acebes, Á., Martín‐Peña, A., Chevalier, V., & Ferrús, A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5046-10.2011 · Cited by 42

Increased Inflammation and Unchanged Density of Synaptic Vesicle Glycoprotein 2A (SV2A) in the Postmortem Frontal Cortex of Alzheimer’s Disease Patients

Metaxas, A., Thygesen, C., Briting, S. R. R., Landau, A. M., Darvesh, S., & Finsen, B. R. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00538 · Cited by 39

Multi-Focal Neuronal Ultrastructural Abnormalities and Synaptic Alterations in Mice after Low-Intensity Blast Exposure

Konan, L., Song, H., Pentecost, G., Fogwe, D. T., Ndam, T., Cui, J., Johnson, C. E., Grant, D. G., White, T., Chen, M., et al. (2019) · Journal of Neurotrauma · doi:10.1089/neu.2018.6260 · Cited by 40

Diffusion Tensor Imaging of the Perforant Pathway Zone and Its Relation to Memory Function in Patients with Severe Traumatic Brain Injury

Christidi, F., Bigler, E., McCauley, S., Schnelle, K. P., Merkley, T. L., Mors, M. B., Li, X.-Q., Macleod, M. C., Chu, Z., Hunter, J., et al. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2010.1644 · Cited by 40

Synaptic dysfunction in human immunodeficiency virus type‐1‐positive subjects: inflammation or impaired neuronal plasticity?

Avdoshina, V., Bachis, A., & Mocchetti, I. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12050 · Cited by 40

Cross-Linking of Cell Surface Amyloid Precursor Protein Leads to Increased -Amyloid Peptide Production in Hippocampal Neurons: Implications for Alzheimer's Disease

Lefort, R., Pozueta, J., & Shelanski, M. L. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6473-11.2012 · Cited by 41

The Effects of Soluble A.β Oligomers on Neurodegeneration in Alzheimer's Disease

Brouillette, J. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990498 · Cited by 39

Rational design, cognition and neuropathology evaluation of QTC-4-MeOBnE in a streptozotocin-induced mouse model of sporadic Alzheimer’s disease

Fronza, M. G., Baldinotti, R., Martins, M. C., Goldani, B. S., Dalberto, B. T., Kremer, F. S., Begnini, K. R., Pinto, L. D. S., Lenardao, E. J., Seixas, F. K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-43532-9 · Cited by 39

Spine pruning in 5xFAD mice starts on basal dendrites of layer 5 pyramidal neurons

Crowe, S. E., & Ellis‐Davies, G. C. R. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0518-6 · Cited by 41

Synapses, Microglia, and Lipids in Alzheimer’s Disease

Paasila, P. J., Aramideh, J. A., Sutherland, G. T., & Graeber, M. B. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.778822 · Cited by 40

Age-dependent alterations in the presynaptic active zone in a Drosophila model of Alzheimer's Disease

Huang, J., Ma, P.-L., Ji, S.-Y., Zhao, X., Tan, J.-X., Sun, X., & Huang, F.-D. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.11.006 · Cited by 41

PET Agents in Dementia: An Overview

van Waarde, A., Marcolini, S., Deyn, P. P. D., & Dierckx, R. (2021) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2020.12.008 · Cited by 39

Advances on the Understanding of the Origins of Synaptic Pathology in AD

Lacor, P. N. (2007) · Current Genomics · doi:10.2174/138920207783769530 · Cited by 40

PAK Inactivation Impairs Social Recognition in 3xTg-AD Mice without Increasing Brain Deposition of Tau and A

Arsenault, D., Dal‐Pan, A., Tremblay, C., Bennett, D. A., Guitton, M. J., Koninck, Y. D., Tonegawa, S., & Calon, F. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1501-13.2013 · Cited by 39

A genetic variant of the Wnt receptor LRP6 accelerates synapse degeneration during aging and in Alzheimer’s disease

Jones, M. E., Buechler, J., Dufor, T., Palomer, E., Teo, S., Martín‐Flores, N., Boroviak, K., Metzakopian, E., Gibb, A. J., & Salinas, P. C. (2023) · Science Advances · doi:10.1126/sciadv.abo7421 · Cited by 35

Apolipoprotein E*4 (APOE*4) Genotype Is Associated with Altered Levels of Glutamate Signaling Proteins and Synaptic Coexpression Networks in the Prefrontal Cortex in Mild to Moderate Alzheimer Disease

Sweet, R. A., MacDonald, M. L., Kirkwood, C. M., Ding, Y., Schempf, T. A., Jones-Laughner, J., Kofler, J., Ikonomović, M. D., López, O. L., Garver, M. E., et al. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.056580 · Cited by 36

Tracing synaptic loss in Alzheimer's brain with SV2A PET‐tracer UCB‐J

Kumar, A., Scarpa, M., & Nordberg, A. K. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13720 · Cited by 36

Long-Term Effects of Intracerebroventricular Streptozotocin Treatment on Adult Neurogenesis in the Rat Hippocampus

Sun, P., Knezović, A., Parlak, M., Cuber, J., Karabeg, M. M., Deckert, J., Riederer, P. F., Hua, Q., Šalković‐Petrišić, M., & Schmitt, A. G. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150710112147 · Cited by 35

NO Orchestrates the Loss of Synaptic Boutons from Adult “Sick” Motoneurons: Modeling a Molecular Mechanism

Moreno‐López, B., Sunico, C. R., & González‐Forero, D. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8159-8 · Cited by 37

A tetra(ethylene glycol) derivative of benzothiazole aniline ameliorates dendritic spine density and cognitive function in a mouse model of Alzheimer's disease

Song, J. M., DiBattista, A. M., Sung, Y. M., Ahn, J. M., Turner, R. S., Yang, J., Pak, D. T. S., Lee, H., & Hoe, H.-S. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.11.023 · Cited by 37

Antagonists targeting eEF2 kinase rescue multiple aspects of pathophysiology in Alzheimer’s disease model mice

Kasica, N. P., Zhou, X., Yang, Q., Wang, X., Yang, W., Zimmermann, H. R., Holland, C. E., Koscielniak, E., Wu, H., Cox, A. O., et al. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15562 · Cited by 34

Chronic γ-secretase inhibition reduces amyloid plaque-associated instability of pre- and postsynaptic structures

Liebscher, S., Page, R., Kaefer, K., Winkler, E., Quinn, K., Goldbach, E. G., Brigham, E. F., Quincy, D. A., Basi, G. S., Schenk, D., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.122 · Cited by 33

Loss of precuneus dendritic spines immunopositive for spinophilin is related to cognitive impairment in early Alzheimer's disease

Mi, Z., Abrahamson, E. E., Ryu, A. Y., Fish, K. N., Sweet, R. A., Mufson, E. J., & Ikonomović, M. D. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.01.022 · Cited by 36

Does the term ‘trophic’ actually mean anti-amyloidogenic? The case of NGF

Calissano, P., Amadoro, G., Matrone, C., Ciafrè, S., Marolda, R., Corsetti, V., Ciotti, M. T., Mercanti, D., Luzio, A. D., Severini, C., et al. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.38 · Cited by 36

Administering crocin ameliorates anxiety‐like behaviours and reduces the inflammatory response in amyloid‐beta induced neurotoxicity in rat

Hadipour, M., Bahari, Z., Afarinesh, M. R., Jangravi, Z., Shirvani, H., & Meftahi, G. H. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13494 · Cited by 33

3D Analysis of the Synaptic Organization in the Entorhinal Cortex in Alzheimer’s Disease

Domínguez-Álvaro, M., Montero‐Crespo, M., Blázquez‐Llorca, L., Plaza‐Alonso, S., Cano‐Astorga, N., DeFelipe, J., & Alonso‐Nanclares, L. (2021) · eNeuro · doi:10.1523/eneuro.0504-20.2021 · Cited by 35

Neurochemical Changes in the Aging Process: Implications in Medication in the Elderly

Anyanwu, E. C. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.112 · Cited by 32

Cdk5 is a New Rapid Synaptic Homeostasis Regulator Capable of Initiating the Early Alzheimer-Like Pathology

Sheng, Y., Zhang, L., Su, S. C., Tsai, L., & Zhu, J. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhv032 · Cited by 32

Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound

Baazaoui, N., & Iqbal, K. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0273-7 · Cited by 31

Astrocytic aerobic glycolysis provides lactate to support neuronal oxidative metabolism in the hippocampus

Dias, C., Fernandes, E., Barbosa, R. M., Laranjinha, J. A. N., & Ledo, A. (2023) · BioFactors · doi:10.1002/biof.1951 · Cited by 30

Nose to Brain Delivery of Nanocarriers Towards Attenuation of Demented Condition

Gorain, B., Rajeswary, D. C., Pandey, M., Kesharwani, P., Kumbhar, S. A., & Choudhury, H. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200313125613 · Cited by 31

Dehydroepiandrosterone (DHEA) and its Sulphate (DHEAS) in Alzheimer’s Disease

Štrac, D. Š., Konjevod, M., Perković, M. N., Tudor, L., Erjavec, G. N., & Pivac, N. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200317092310 · Cited by 31

Pin1 mediates Aβ 42 -induced dendritic spine loss

Stallings, N. R., O’Neal, M. A., Hu, J., Kavalali, E. T., Борисович, Б. И., & Malter, J. S. (2018) · Science Signaling · doi:10.1126/scisignal.aap8734 · Cited by 29

Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer’s Disease: Implications from a Transgenic Mouse Model of the Disease

Baazaoui, N., Flory, M. J., & Iqbal, K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160845 · Cited by 31

Role of PDE9 in Cognition

Dorner‐Ciossek, C., Kroker, K. S., & Rosenbrock, H. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-58811-7_9 · Cited by 29

The contribution of microglia to early synaptic compensatory responses that precede β-amyloid-induced neuronal death

Merlo, S., Spampinato, S. F., Beneventano, M., & Sortino, M. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-25453-1 · Cited by 29

Comparative analysis of autophagy and tauopathy related markers in cerebral ischemia and Alzheimer’s disease animal models

Villamil-Ortiz, J., & Cardona-Gómez, G. P. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00084 · Cited by 29

ApoE4 Induces Synaptic and ERG Impairments in the Retina of Young Targeted Replacement ApoE4 Mice

Antes, R., Ezra-Elia, R., Weinberger, D., Solomon, A., Ofri, R., & Michaelson, D. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064949 · Cited by 29

Dissociable Effects of Aging and Mild Cognitive Impairment on Bottom-Up Audiovisual Integration

Festa, E. K., Katz, A. P., Ott, B. R., Tremont, G. N., & Heindel, W. C. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161062 · Cited by 29

Age-related decline of neuroplasticity to intermittent theta burst stimulation of the lateral prefrontal cortex and its relationship with late-life memory performance

Goldsworthy, M. R., Rogasch, N. C., Ballinger, S., Graetz, L. J., Dam, J. M. V., Harris, R. J., Yu, S., Pitcher, J. B., Baune, B. T., & Ridding, M. C. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2020.06.015 · Cited by 28

Identification of BDNF Sensitive Electrophysiological Markers of Synaptic Activity and Their Structural Correlates in Healthy Subjects Using a Genetic Approach Utilizing the Functional BDNF Val66Met Polymorphism

Soltész, F., Suckling, J., Lawrence, P., Tait, R. J., Ooi, C., Bentley, G., Dodds, C. M., Miller, S. R., Willé, D. R., Byrne, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095558 · Cited by 25

Pharmacological Strategies to Improve Dendritic Spines in Alzheimer’s Disease

Ettcheto, M., Busquets, O., Cano, A. C., Sánchez‐López, E., Manzine, P. R., Espinosa-Jiménez, T., Verdaguer, E., Sureda, F. X., Olloquequi, J., Castro-Torres, R. D., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-201106 · Cited by 25

Alzheimer’s Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound

Baazaoui, N., & Iqbal, K. (2022) · Biomolecules · doi:10.3390/biom12101409 · Cited by 27

Synaptic vesicle glycoprotein 2A (SV2A) levels in the cerebral cortex in patients with Alzheimer's disease: a radioligand binding study in postmortem brains

Mikkelsen, J. D., Kaad, S., Aripaka, S. S., & Finsen, B. R. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.05.003 · Cited by 24

A histological study of toxic effects of aluminium sulfate on rat hippocampus

Çabuş, N., Oğuz, E., Tufan, A. C., & Adıgüzel, E. (2014) · Biotechnic & Histochemistry · doi:10.3109/10520295.2014.965277 · Cited by 26

Functional tolerance to mechanical deformation developed from organotypic hippocampal slice cultures

Kang, W. H., & Morrison, B. (2014) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-014-0622-4 · Cited by 25

Autobiographical Memory Performance in Alzheimer’s Disease Depends on Retrieval Frequency

Müller, S., Mychajliw, C., Reichert, C., Melcher, T., & Leyhe, T. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151071 · Cited by 27

Beta amyloid peptide plaques fail to alter evoked neuronal calcium signals in APP/PS1 Alzheimer's disease mice

Briggs, C. A., Schneider, C., Richardson, J. C., & Stutzmann, G. E. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.013 · Cited by 26

Transgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer’s disease

Bories, C., Arsenault, D., Lemire, M., Tremblay, C., Koninck, Y. D., & Calon, F. (2017) · Aging · doi:10.18632/aging.101239 · Cited by 25

Differential Pattern of Phospholipid Profile in the Temporal Cortex from E280A-Familiar and Sporadic Alzheimer’s Disease Brains

Villamil-Ortiz, J. G., Barrera-Ocampo, A., Arias-Londoño, J. D., Villegas, A., Lopera, F., & Cardona-Gómez, G. P. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170554 · Cited by 24

Implementing Neuronal Plasticity in NeuroAIDS: the Experience of Brain-derived Neurotrophic Factor and other Neurotrophic Factors

Mocchetti, I., Bachis, A., Campbell, L. A., & Avdoshina, V. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9488-y · Cited by 23

Tau-Mediated Dysregulation of Neuroplasticity and Glial Plasticity

Koller, E. J., & Chakrabarty, P. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00151 · Cited by 23

SPG302 Reverses Synaptic and Cognitive Deficits Without Altering Amyloid or Tau Pathology in a Transgenic Model of Alzheimer's Disease

Trujillo‐Estrada, L., Vanderklish, P. W., Nguyen, M. M. T., Kuang, R. R., Nguyen, C., Huynh, E., da Cunha, C., Javonillo, D. I., Forner, S., Martini, A. C., et al. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01143-1 · Cited by 22

Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease

Shantaraman, A., Dammer, E. B., Ugochukwu, O., Duong, D. M., Yin, L., Carter, E. K., Gearing, M., Chen‐Plotkin, A. S., Lee, E. B., Trojanowski, J. Q., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00749-1 · Cited by 23

Nanotechnology Building Blocks for Intervention with Alzheimer’s Disease Pathology: Implications in Disease Modifying Strategies

Nazem, A. (2014) · Journal of Bioanalysis & Biomedicine · doi:10.4172/1948-593x.1000101 · Cited by 20

Hirano body expression impairs spatial working memory in a novel mouse model

Furgerson, M., Clark, J. K., Crystal, J. D., Wagner, J. J., Fechheimer, M., & Furukawa, R. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0131-9 · Cited by 25

Alzheimer’s disease: from early pathogenesis to novel therapeutic approaches

Prajapati, S. K., Pathak, A., & Samaiya, P. K. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01389-6 · Cited by 21

Glycogen and amyloid-beta: key players in the shift from neuronal hyperactivity to hypoactivity observed in Alzheimer′s disease?

Murray, I. V. J., Bass, B., Upson, S., Roy, K., Montgomery, E., & Jalonen, T. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.160059 · Cited by 21

Utility of imaging for nutritional intervention studies in Alzheimer's disease

de Wilde, M. C., Kamphuis, P. J. G. H., Sijben, J., & Scheltens, P. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.07.011 · Cited by 21

Ca2+-Permeable TRPV1 Receptor Mediates Neuroprotective Effects in a Mouse Model of Alzheimer’s Disease via BDNF/CREB Signaling Pathway

Kim, J., Seo, S., Park, J. H. Y., Lee, K. W., Kim, J., & Kim, J. (2023) · Molecules and Cells · doi:10.14348/molcells.2023.2156 · Cited by 20

The Association of Amyloid-β Protein Precursor With α- and β-Secretases in Mouse Cerebral Cortex Synapses Is Altered in Early Alzheimer’s Disease

Pliássova, A., Lopes, J. P., Lemos, C., Oliveira, C. R., Cunha, R. A., & Agostinho, P. M. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9491-9 · Cited by 21

Souvenaid®: A new approach to management of early Alzheimer's disease

Ritchie, C. W., Bajwa, J., Coleman, G., Hope, K. W., Jones, R. W., Lawton, M., Marven, M., & Passmore, P. (2013) · The journal of nutrition health & aging · doi:10.1007/s12603-013-0411-2 · Cited by 20

Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound

Baazaoui, N., & Iqbal, K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170075 · Cited by 20

Danggui Buxue decoction ameliorates mitochondrial biogenesis and cognitive deficits through upregulating histone H4 lysine 12 acetylation in APP/PS1 mice

Chai, G., Gong, J., Wu, J., Ma, R.-K., Zhu, J., Jia, D., Zhang, Y., Zhai, X.-R., Sun, H., Nie, Y. J., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116554 · Cited by 19

Synaptic and Sub-Synaptic Localization of Amyloid-β Protein Precursor in the Rat Hippocampus

Rodrigues, D. I., Gutierres, J. M., Pliássova, A., Oliveira, C. R., Cunha, R. A., & Agostinho, P. M. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132030 · Cited by 18

AD-Related N-Terminal Truncated Tau Is Sufficient to Recapitulate In Vivo the Early Perturbations of Human Neuropathology: Implications for Immunotherapy

Borreca, A., Latina, V., Corsetti, V., Middei, S., Piccinin, S., Valle, F. D., Bussani, R., Ammassari‐Teule, M., Nisticò, R., Calissano, P., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0974-3 · Cited by 18

Mechanisms of vagal plasticity influencing feeding behavior

de Lartigue, G., & Xu, C. Y. (2018) · Brain Research · doi:10.1016/j.brainres.2018.03.030 · Cited by 18

Firing rate homeostasis counteracts changes in stability of recurrent neural networks caused by synapse loss in Alzheimer’s disease

Bachmann, C., Tetzlaff, T., Duarte, R., & Morrison, A. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007790 · Cited by 19

Altered Expression of Circulating Cdc42 in Frontotemporal Lobar Degeneration

Saraceno, C., Catania, M., Paterlini, A., Fostinelli, S., Ciani, M., Zanardini, R., Binetti, G. G., Fede, G. D., Caroppo, P., Benussi, L., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170722 · Cited by 18

Adult-onset focal expression of mutated human tau in the hippocampus impairs spatial working memory of rats

Mustroph, M. L., King, M. A., Klein, R. L., & Ramirez, J. J. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.04.034 · Cited by 23

Dissecting the molecular mechanism by which NH2htau and Aβ1-42 peptides impair mitochondrial ANT-1 in Alzheimer disease

Bobba, A., Amadoro, G., Petragallo, V. A., Calissano, P., & Atlante, A. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2013.04.001 · Cited by 17

Biomarkers Related to Synaptic Dysfunction to Discriminate Alzheimer’s Disease from Other Neurological Disorders

Piccoli, T., Blandino, V., Maniscalco, L., Matranga, D., Graziano, F., Guajana, F., Agnello, L., Sasso, B. L., Gambino, C. M., Giglio, R. V., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810831 · Cited by 16

Bayesian integrative analysis of epigenomic and transcriptomic data identifies Alzheimer's disease candidate genes and networks

Klein, H., Schäfer, M. K.-H., Bennett, D. A., Schwender, H. R., & Jager, P. L. D. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007771 · Cited by 17

Functional parcellation of the hippocampus based on its layer-specific connectivity with default mode and dorsal attention networks

Deshpande, G., Zhao, X., & Robinson, J. L. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119078 · Cited by 15

Vesicular Glutamate Transporter Changes in the Cortical Default Mode Network During the Clinical and Pathological Progression of Alzheimer’s Disease

Mi, Z., Abrahamson, E. E., Ryu, A. Y., Malek‐Ahmadi, M. H., Kofler, J., Fish, K. N., Sweet, R. A., Villemagne, V. L., Schneider, J. A., Mufson, E. J., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221063 · Cited by 15

Pros and Cons of APOE4 Homozygosity and Effects on Neuroplasticity, Malnutrition, and Infections in Early Life Adversity, Alzheimer’s Disease, and Alzheimer’s Prevention

Oriá, R. B., Smith, C. J., Ashford, J. W., Vitek, M. P., & Guerrant, R. L. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240888 · Cited by 16

A systematic review on drugs for synaptic plasticity in the treatment of dementia

Piscopo, P., Crestini, A., Carbone, E., Rivabene, R., Ancidoni, A., Giudice, M. L., Corbo, M., Vanacore, N., & Lacorte, E. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101726 · Cited by 16

A novel approach for ganglioside structural analysis based on electrospray multiple-stage mass spectrometry.

Zamfir, A. D., Vukelić, Ž., Schneider, A., Şişu, E., Dincă, N., & Ingendoh, A. (2007) · PubMed Central · Cited by 13

ERK activation and expression of neuronal cell cycle markers in the hippocampus after entorhinal cortex lesion

Hernández‐Ortega, K., & Arias, C. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23106 · Cited by 13

Dose-dependent improvements in learning and memory deficits in APPPS1-21 transgenic mice treated with the orally active Aβ toxicity inhibitor SEN1500

Lo, A. C., Tesseur, I. C., Scopes, D. I. C., Nerou, E., Callaerts‐Vegh, Z., Vermaercke, B., Treherne, J. M., Strooper, B. D., & D’Hooge, R. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.030 · Cited by 11

Rostral-Caudal Hippocampal Functional Convergence Is Reduced Across the Alzheimer’s Disease Spectrum

Initiative, A. D. N., Therriault, J., Wang, S., Mathotaarachchi, S. S., Pascoal, T. A., Parent, M. J., Beaudry, T., Shin, M., Benedet, A. L., Kang, M. S., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01671-0 · Cited by 12

Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies

Scheff, S. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.002 · Cited by 391

Synaptic Pathology in Dementia

Scheff, S. W. (2006) · Springer eBooks · doi:10.1007/978-0-387-32562-0_30

Quantitative Assessment of Synaptic Density in the Outer Molecular Layer of the Hippocampal Dentate Gyrus in Alzheimer's Disease

Scheff, S. W., Sparks, D. L., & PRICE, D. A. (1996) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106884 · Cited by 95

Quantitative assessment of cortical synaptic density in Alzheimer's disease

Scheff, S. W., DeKosky, S. T., & Price, D. A. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90059-9 · Cited by 446

Neuronal Death versus Synaptic Pathology in Alzheimer's Disease

Bertoni–Freddari, C., Fattoretti, P., Solazzi, M., Giorgetti, B., Stefano, G. D., Casoli, T., & Meier-Ruge, W. A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1299.116 · Cited by 30